Postmenopausal Osteoporosis: Diagnosis, FRAX® and Management
https://doi.org/10.33591/sfp.45.7.u1
- Author:
Seng Bin Ang
- Publication Type:Journal Article
- Keywords:
Osteoporosis screening;
osteoporosis treatment;
OSTA;
FRAX
- From:The Singapore Family Physician
2019;45(7):8-15
- CountrySingapore
- Language:English
-
Abstract:
Osteoporosis-related fractures are increasing at a rapid rate, especially in Asia due to the ageing population. This would result in increased morbidity and mortality of the seniors as well as creating a strain on the healthcare system. Efforts should be made to prevent osteoporosis, screen for osteoporosis early and timely treatment to reduce the risk of fractures. As falls are a major risk factor for fracture in osteoporotic patients, management of
osteoporosis should include efforts to reduce falls. Using a population-wide strategy for women 65 years old couple with high-risk population screening using a combination of tools such as FRAX® and OSTA as well as clinical risk factors for women below 65 years old can
detect osteoporosis early for intervention. Treatment options for osteoporosis include
bisphosphonates, denosumab, teriparatide, raloxifene, menopausal hormone therapy and tibolone. Drug choices should be individualised to the patient, balancing the risk/benefit ratio.
